Director Jeffrey A. Craig receives 12,836 Baxter (BAX) shares in grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Craig Jeffrey A reported acquisition or exercise transactions in this Form 4 filing.
Baxter International director Jeffrey A. Craig received an equity grant of 12,836 shares of Baxter common stock on May 5, 2026. The shares were granted at no cost as fully vested stock, subject to the applicable grant terms. Following this award, Craig directly holds 23,662 shares, a figure that also reflects automatic reinvestment of dividends.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Craig Jeffrey A
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $1 par value | 12,836 | $0.00 | -- |
Holdings After Transaction:
Common Stock, $1 par value — 23,662 shares (Direct, null)
Footnotes (1)
- The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends.
Key Figures
Equity grant: 12,836 shares
Holdings after grant: 23,662 shares
Grant price per share: $0.00 per share
3 metrics
Equity grant
12,836 shares
Common stock grant to director on May 5, 2026
Holdings after grant
23,662 shares
Director’s direct Baxter common stock holdings following award
Grant price per share
$0.00 per share
Reported transaction price for the awarded common stock
Key Terms
fully vested shares of common stock, automatic reinvestment of dividends, grant of fully vested shares
3 terms
automatic reinvestment of dividends financial
"Total includes the automatic reinvestment of dividends."
FAQ
What insider transaction did Baxter (BAX) report for Jeffrey A. Craig?
Baxter reported that director Jeffrey A. Craig received a grant of 12,836 fully vested common shares. The award was made at no cost as stock-based compensation, increasing his direct holdings to 23,662 shares, including shares from automatic dividend reinvestment.
Was the Baxter (BAX) Form 4 transaction a market purchase or a grant?
The Form 4 transaction was a stock grant, not a market purchase. Craig received 12,836 fully vested Baxter common shares at a reported price of $0.00 per share, reflecting compensation awarded under Baxter’s grant terms rather than an open-market buy.
Does the Baxter (BAX) Form 4 mention dividend reinvestment for Craig’s holdings?
Yes. A footnote states Craig’s total share count includes automatic reinvestment of dividends. This means dividends paid on previously held Baxter shares were used to acquire additional shares, which are reflected in the reported 23,662-share holding total.